Top Markets
#1 Pleasing Gold Pleasing Gold +1,049.05%
#2 PulseChain PulseChain +56.20%
#3 BOOK OF MEME BOOK OF MEME +39.77%
#4 DogBull DogBull +36.97%
#5 Ontology Gas Ontology Gas +31.77%
#6 Pump.fun Pump.fun +21.94%
#7 Unit Pump Unit Pump +21.94%
#8 Neiro Neiro +21.70%
#9 Collect on Fanable Collect on Fanable +19.20%
#10 rsERG rsERG +17.92%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ProMIS Neurosciences, Inc. ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc.

PMN
Classement en actions #26784
Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing... Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing precise medical solutions for severe neurodegenerative disorders, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company employs a unique discovery platform, which incorporates proprietary algorithms like ProMIS and Collective Coordinates, to identify novel, disease-specific targets, known as epitopes, located on the surface of misfolded proteins. The firm's primary product candidates include PMN310, a monoclonal antibody designed to combat toxic oligomers associated with Alzheimer's disease. Another candidate, PMN267, aims to target proteins such as superoxide dismutase 1 and TAR-DNA binding protein 43 relevant to ALS, as well as alpha-synuclein implicated in Parkinson's disease and Lewy body dementia. Additionally, PMN442 is a monoclonal antibody engineered to address toxic alpha-synuclein oligomers and seeding fibrils linked to MSA. Originally established in 2004, the company was known as Amorfix Life Sciences Ltd. before officially adopting the name ProMIS Neurosciences, Inc. in July 2015.
Prix de l'action
$4.40
Dernière synchronisation: 2023-07-21
Capitalisation boursière
$37.78M
Changement (1 jour)
-7.03%
Changement (1 an)
0.00%
Pays
CA
Échange ProMIS Neurosciences, Inc. (PMN)

Catégorie

Healthcare
Historique du prix de l'action pour ProMIS Neurosciences, Inc. (PMN)
Prix de clôture le plus élevé : $3.87 le 2023-07-01

Prix de clôture le plus bas : $70.47 le 2007-10-01
Historique du prix de l'action de ProMIS Neurosciences, Inc. de 2007 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -22.04%
2022 -21.52%
2021 49.13%
2020 -49.02%
2019 -16.16%
2018 -2.72%
2017 52.98%
2016 155.29%
2015 -71.77%
2014 -49.01%
2013 -24.02%
2012 80.59%
2011 -48.53%
2010 -50.72%
2009 192.28%
2008 -73.58%
2007 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $546.40 38.55%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 55.80%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.76 430.90%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.46%
CH